Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7302
    +0.0004 (+0.06%)
     

  • CRUDE OIL

    82.78
    -0.03 (-0.04%)
     

  • Bitcoin CAD

    88,112.02
    -3,154.73 (-3.46%)
     

  • CMC Crypto 200

    1,389.34
    -34.76 (-2.44%)
     

  • GOLD FUTURES

    2,321.90
    -16.50 (-0.71%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,463.00
    -201.50 (-1.14%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,818.11
    -641.97 (-1.67%)
     

  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

Stocks in play: Canopy Growth Corporation

Baystreet.ca

Submitted its final documentation for its beverage facility to Health Canada in late June 2019 and subsequently received the licence in late November 2019. In the seven weeks since receiving the licence, the Company has made meaningful progress towards scaling the production process for its cannabis beverages from lab scale to commercial scale. Canopy Growth Corporation shares T.WEED are trading up $0.44 at $32.11.

Read: Why 2020 Should be a Big Year for Psilocybin "Magic" Mushrooms